AB&B BIO-TECH-B applies for full circulation of H shares
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, AB&B BIO-TECH-B announced that on October 15, 2025, the company has submitted an application to the China Securities Regulatory Commission for the conversion of 81.662 million unlisted shares into H shares and for the listing of such shares on the Stock Exchange of Hong Kong
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments